Test1

The chart shows the growth of an initial investment of $10,000 in Test1, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Aug 3, 2024, Test1's average daily return is +0.05%, while the average monthly return is +1.61%. At this rate, your investment would double in approximately 3.6 years.

Historically, 71% of months were positive and 29% were negative. The best month was Apr 2026 with a return of +6.4%, while the worst month was Mar 2026 at -7.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 2 months.

On a daily basis, Test1 closed higher 54% of trading days. The best single day was Apr 8, 2026 with a return of +3.2%, while the worst single day was Apr 4, 2025 at -4.3%.

Test1 has an annualized alpha of 14.60%, beta of 0.46, and R² of 0.35 versus S&P 500 Index. Calculated based on daily prices since August 03, 2024.

• This portfolio captured 112.77% of S&P 500 Index gains but only 74.12% of its losses — a favorable profile for investors.
• Beta of 0.46 may look defensive, but with R² of 0.35 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
• R² of 0.35 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Test1 has an expense ratio of 0.41%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Test1 ranks 41 for risk / return — on par with similar portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Test1 Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

• 1-Year: 2.64
• All Time: 1.57

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of Test1 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Test1 provided a 0.61% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Test1. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Test1 was 15.69%, occurring on Apr 7, 2025. Recovery took 41 trading sessions.

The current Test1 drawdown is 3.39%.

The chart below shows the rolling one-month volatility.